Shingles NHS Jabs: Why People Are Missing Out
Shingles Vaccine Uptake Low Despite High Efficacy, Leaving Millions at Risk
Table of Contents
New study reveals widespread misunderstanding of eligibility for the shingrix jab, as campaigners call for an end to age restrictions.
Millions of Over-65s Unaware of Shingles Vaccine Benefits
Despite the Shingrix vaccine offering a remarkable 90 per cent reduction in the risk of shingles infection, a significant portion of the UK’s older population remains unvaccinated. New research, conducted by GSK – the British pharmaceutical giant behind the jab – has highlighted a concerning lack of awareness regarding vaccine eligibility, with manny over-65s mistakenly believing they can still receive the vaccine beyond the age of 80, the current cut-off point for NHS provision.
The study, which surveyed over 2,000 individuals aged 65 and above, found that less then half of all 71-year-olds have been vaccinated. Even more alarmingly, fewer than one in five of those who turned 65 this year have received the two-dose Shingrix vaccine, which replaced a less effective predecessor in September 2023.
Campaigners Demand End to “Discriminatory” Age Restrictions
The phased rollout of Shingrix, necessitated by high global demand, has left a significant segment of the population vulnerable. Campaigners are now urging the government to address what they describe as “discrimination” against the three million people aged between 66 and 69 who are currently ineligible for the vaccine on the NHS.
Senior citizens’ advocacy group,Silver Voices,has led the charge,calling for the NHS to abolish the age restriction. They warn that the current policy exposes millions to needless risk and suffering from the debilitating effects of shingles.
Personal Accounts Highlight the Devastating Impact of Shingles
The importance of vaccination is underscored by the harrowing experience of 72-year-old Daniel Hill. While on holiday in Majorca, Mr. Hill developed a painful rash on his back, which was diagnosed as shingles by a local doctor. Despite being prescribed antiviral medication, he was unprepared for the severity of the pain that followed.”Moments after leaving the clinic, the pain struck ‘like someone had taken an axe to my back’,” Mr. Hill recounted.He spent the remainder of his holiday confined to his bed,enduring excruciating agony.
“You really don’t want to get shingles,” he emphasized. “I wish I’d known the vaccine was available on the NHS – I was eligible but had no idea. It’s so crucial to check if you qualify and, if you do, get vaccinated to avoid the terrible impact it can have.”
Mr. Hill’s experience serves as a stark reminder of the potentially life-altering consequences of shingles and the critical need for greater public awareness and equitable access to preventative measures like the Shingrix vaccine. The ongoing debate highlights a pressing public health issue that requires urgent attention to protect the well-being of the nation’s seniors.